Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment.

MLA

Wong, Simon G., et al. “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment.” Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 49, no. 1, Jan. 2021, pp. 94–110. EBSCOhost, https://doi.org/10.1124/dmd.120.000055.

APA

Wong, S. G., Ramsden, D., Dallas, S., Fung, C., Einolf, H. J., Palamanda, J., Chen, L., Goosen, T. C., Siu, Y. A., Zhang, G., Tweedie, D., Hariparsad, N., Jones, B., & Yates, P. D. (2021). Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 49(1), 94–110. https://doi.org/10.1124/dmd.120.000055

Chicago

Wong, Simon G, Diane Ramsden, Shannon Dallas, Conrad Fung, Heidi J Einolf, Jairam Palamanda, Liangfu Chen, et al. 2021. “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment.” Drug Metabolism and Disposition: The Biological Fate of Chemicals 49 (1): 94–110. doi:10.1124/dmd.120.000055.